ELF3 and hematologic disorder: Thus, to the authors’ knowledge, the present study produced a unique opportunity to understand possible mechanisms of ERT action on proliferation, differentiation, and redox adaptation processes in K562 erythroid cells to provide subsidies for its use as an adjuvant in the treatment of hematological diseases presenting oxidative stress as a pathophysiological consequence.